Breega
22 rue de Palestro, Paris, Île-de-France, 75002, France
Overview
Breega propels pioneering and purpose-driven founders from idea into impact. We closed our first fund in 2015 and now have half a billion AUM and 70+ trailblazing portfolio companies. Crafted for founders by founders, we built Breega to provide start-ups with the help we wish we'd had. And we’ve created an investment proposition that’s purposefully designed. We call it full stack funding: providing capital and connections, expertise and experience, support and solidarity for entrepreneurs at every step of their journey. We invest across Europe and internationally, focusing on pre-seed to Series A+.
- Total investments
- 84
- Lead investments
- 33
- Investments · 12mo
- 7
- Active investors
- 12
Sector focus
- Blockchain
- Finance
- Financial Services
- FinTech
- Impact Investing
- InsurTech
- Venture Capital
Investment portfolio
- Biochar Industrial Group
Participated · Seed · Aug 2026
Biochar Industrial Group (BIG) is described in coverage as a Nigerian climate tech startup. The company recently completed a $1.5M pre-seed financing backed by Catalyst Fund, BREEGA and Mulago Foundation. The announced financing is the only funding event reported in the articles. The reporting does not provide details on the company’s products, operating metrics, revenue, or specific plans for the new capital. No founding year or additional location details were provided in the articles. There are no disclosed financial metrics or user figures in the coverage.
- BioOrbit
Led · Seed · Apr 2026
BioOrbit develops compact, modular autonomous manufacturing units called BOX to perform crystallisation of biological drugs in microgravity at industry-relevant scale. The company positions BOX as a microwave-sized payload that moves crystallisation from one-off experiments to repeatable manufacturing pathways not achievable on Earth. BioOrbit says its technology enables better-performing biologics and is engaging with the NHS and the UK Space Agency while working on regulatory pathways with the MHRA, Regulatory Innovation Office and CAA. The company was founded and funded by Dr. Katie King and co-founder oncology researcher Dr. Leonor Teles and has appointed senior pharma-and-space executives to its leadership team. BioOrbit has participated in accelerators including Airbus Accelerator, Seraphim Space Accelerator, ESA BSGN Life Sciences, ESA BIC UK and the UK Space Agency LEO Accelerator. The articles do not disclose current revenue or user metrics.
- Keith
Participated · Seed · Mar 2026
Keith is a UK-based, AI-native law firm founded by Andy Shovel, Pete Sharman, and Sam Tucker that aims to be a fully regulated practice with AI at its core. The firm plans to start by serving conveyancing clients and then expand into other practice areas. Keith says it intends to automate up to 80% of traditionally human legal work through a network of specialised AI agents for document review, drafting, communication, and workflow management, all within controlled legal frameworks and subject to human oversight. It will offer 24/7 client service via phone and WhatsApp and emphasises faster response times and continuous operation. The company cites problems in the UK property market—more than 530,000 collapsed transactions annually—and targets the €62.4 billion UK legal market as ripe for disruption. Eddie Goldsmith is listed as strategic advisor and non-executive director, and the firm is hiring ahead of a planned Q3 2026 launch.
- Quideos
Led · Equity · Jan 2026
Founded in 2023 by Gaël Pagès and Mickaël Delmas, Quideos builds derivative-style coverage contracts that let farmers, cooperatives and agri-food companies lock in an agreed purchase or sale price over a chosen period. Clients pay a premium that varies with volume, duration and target price; if market prices fall, Quideos pays a cash compensation, while rising prices leave the premium as the only cost, ensuring there is no speculative usage. The company bases its indices on public and private data sources such as Insee, FranceAgriMer and the European Commission. After an 18-month process, it secured a Class 2 investment-firm licence from the ACPR, enabling it to market the product within a regulated framework. More than 80 % of agricultural goods currently lack protection mechanisms, a gap Quideos aims to fill. With fresh funding it will convert an existing pipeline of prospects into active customers and begin hiring additional staff from 2026. By 2029 the startup targets coverage of €1 billion in agricultural purchases or sales and plans a phased expansion into other European markets once domestic scale is achieved.
- Edailabs
Participated · Seed · Dec 2025
Founded in 2023, Edailabs develops EMMA, a mobile application that enables users to practice English through real-time conversations with a personalized 3D avatar driven by conversational AI. The app provides immediate corrections, operates 24/7, and adapts each learning path via a reinforcement-based personalization algorithm. EMMA has attracted strong early traction, amassing more than 500,000 registered users and 20,000 App Store reviews with an average rating of 4.7/5. Users praise its judgment-free environment, flexibility, and high engagement, turning many into organic ambassadors. Edailabs positions EMMA at the intersection of chatbot AI and immersive 3D to capture a share of the global English-learning market of over 1.5 billion potential speakers. Future plans include adding new interactive scenarios, expanding into additional languages, and entering new geographic markets. This roadmap aims to elevate performance benchmarks within the EdTech sector and cement the company’s status as a global player.